Clever Leaves Holdings Inc. CLVR
At closeNov 3, 2026, 4:00 PM EST
- YTD
- +5,500.00%
- 1 year
- +11,100.00%
- Market cap
- 19.65K
- Revenue (ttm)
- 17.42M
- Profit margin
- -102.77%
- EPS (ttm)
- -353.64
- Shares out
- 1.75M
- Forward P/E
- -0.48
- YTD return
- +5500.00%
- 1-year return
- +11100.00%
- Volume
- 25.27K
- Avg volume
- 38
- Open
- 0.0001
- Previous close
- 0.0112
- Day's range
- 0.0001 – 0.0001
- 52-week range
- 0.0001 – 0.025
- Beta
- 2.02
- Analysts
- Hold
2Y +0.0111 (+11100.00%)
Key statistics
- Enterprise value
- 1.05M
- PEG ratio
- 0.00
- Price / sales
- 0.32
- Price / book
- 0.23
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 5.40%
- Free cash flow
- -2.25M
- Total cash
- 6.83M
- Total debt
- 2.09M
- Return on equity
- -61.27%
- Short % of float
- 2.17%
- 50-day average
- 3.26
- 200-day average
- 3.10
Analyst view
Consensus: hold
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Apr 1, 2024 | Dec 1, 2023 | 0.00 | -2.96 | — | — |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | -4.60 | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | -2.10 | — | — |
| May 11, 2023 | Mar 1, 2023 | 0.00 | -2.70 | — | — |
| Mar 30, 2023 | Dec 1, 2022 | 0.00 | -3.90 | — | — |
| Nov 9, 2022 | Sep 1, 2022 | 0.00 | -5.71 | — | — |
About Clever Leaves Holdings Inc.
Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers—Specialty & Generic
- Country
- Colombia
- Website
- cleverleaves.com
News
Comparing Clever Leaves (NASDAQ:CLVR) and Palatin Technologies (PINK:PTNT) 
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report 
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report 
Watching Cannabis Stocks; Marijuana Moment Reports 'Trump White House Invites Proposal On Federal Marijuana Legalization, Activist Says' 
S&P 500 Edges Higher; ON Semiconductor Earnings Top Views 
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Crude Oil Down Over 1%; Deciphera Pharmaceuticals Shares Spike Higher
Why Philips Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket 
Clever Leaves Announces Voluntary Delisting and SEC Deregistration 
Clever Leaves Reports Fourth Quarter and Full Year 2023 Results
Your note
Sign in to keep a note on CLVR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DEFFARGES ETIENNE H | Director | Stock Award(Grant) | Jun 28, 2021 | 13,469 |
| DEMARSE ELISABETH H | Director | Stock Award(Grant) | May 30, 2023 | 122,276 |
| DETWILER KYLE PAUL | Chief Executive Officer | Stock Award(Grant) | Jan 13, 2022 | 2,652,770 |
| FAJARDO ANDRES | Chief Executive Officer | Sale | Jan 18, 2024 | 35,315 |
| HAGUE HENRY R III | Chief Financial Officer | Sale | Mar 7, 2024 | 11,951 |
| JULIEN GARY M. | Director | Sale | Jun 28, 2023 | 122,025 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Farallon Capital Management Llc | 0.12% | 54,312 | 330.27K | Jun 29, 2023 |
| AdvisorShares Investments, LLC | 0.08% | 35,488 | 215.80K | Jun 29, 2023 |
| Renaissance Technologies, LLC | 0.05% | 23,588 | 143.44K | Jun 29, 2023 |
| FNY Investment Advisers, LLC | 0.04% | 19,985 | 68.95K | Sep 29, 2023 |
| Vanguard Group Inc | 0.03% | 14,914 | 90.69K | Jun 29, 2023 |
| Amundi | 0.02% | 8,444 | 51.35K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| AdvisorShares Trust-AdvisorShares Pure Cannabis ETF | 0.08% | 35,081 | 121.03K | Sep 29, 2023 |
| Vanguard Extended Market Index Fund | 0.03% | 14,716 | 89.49K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.01% | 3,421 | 25.62K | May 30, 2023 |
| Amplify Seymour Cannabis ETF | 0.01% | 5,093 | 32.39K | Jul 30, 2023 |